Voice Intelligence for Financial Services
Every financial conversation carries signals traditional systems miss. TruVX uses passive voice intelligence to identify cognitive, emotional, and behavioral risk in real time.
The U.S. life insurance industry processes 10 million applications per year. A meaningful percentage involve phone-based interviews — yet underwriters have no visibility into the cognitive or emotional state of the applicant during that call.
FINRA broker-dealers face potential fines exceeding $1 million per violation for supervision failures. Most compliance review happens after the conversation ends.
Agent attrition costs an average of $10,000–$15,000 per departing agent. At 30–45% annual turnover, a 500-seat contact center loses $1.5M–$3M per year in attrition costs alone — before a single burnout signal is detected.
TruVX adds a new intelligence layer to the conversations already happening across financial services.
TruVX analyzes acoustic patterns in natural speech, not the words spoken, to surface indicators of cognitive load, stress, emotional state and behavioral anomaly.
No new forms. No new surveys. No added friction. Just intelligence from the call already taking place.
Meaningful signal from as little as 40 seconds of natural speech.
Runs during existing phone-based workflows. No behavior change required from customers or employees.
Designed for consent-based deployment in financial services. Built on Microsoft-certified infrastructure with human review and decision-support intelligence.
Clinically validated voice biomarker platform with peer-reviewed research, patent-backed technology, and healthcare deployment experience. HIPAA compliant.
TruVX is powered by Canary Speech's voice biomarker platform, which analyzes millions of acoustic data elements from short natural speech samples. The platform detects patterns related to cognitive load, stress, emotional state, and behavioral anomaly using acoustic properties rather than spoken content.
TruVX analyzes rhythm, cadence, micro-tremors, latency and other acoustic markers from natural speech. No transcription. No content analysis. Pure signal.
Powered by Canary Speech technology validated across healthcare and research environments. 23 issued patents, 19 pending. Peer-reviewed science deployed across leading telehealth platforms.
Designed to integrate with existing telephony, call center, CCaaS, compliance, underwriting and enterprise systems. Minimal IT footprint. No audio storage required.
Focused on acoustic patterns, consent-based deployment, human review, and decision support. Never transcribes or stores spoken content. No PII derived from audio. No automated decisioning.
TruVX is purpose-built for financial services: insurance, banking, wealth management, and enterprise contact center environments.
TruVX identifies signals that static data, forms and after-the-fact reviews often miss. Cognitive load, emotional state, and behavioral anomaly become visible intelligence for the first time.
No new customer behavior. No additional surveys. No operational disruption. TruVX runs during the conversations already happening across your organization. Implementation with no new customer friction and typical deployment in under 30 days.
TruVX surfaces structured risk intelligence for review by underwriters, compliance officers and supervisors. Humans make the decisions. TruVX provides the signal.
Traditional conversation analytics transcribe and analyze content — what was said. TruVX analyzes acoustic properties — how it was said. No transcription means no content privacy risk and no language dependency.
TruVX provides financial services intelligence powered by Canary Speech's patented vocal biomarker platform. Focused on high-stakes financial services environments where better signal can improve risk assessment, compliance, workforce wellness and customer protection.
The owl represents vigilance, wisdom, and the ability to perceive what others cannot see. In financial services, the most consequential risks hide in plain sight. TruVX exists to surface the signals that traditional systems overlook.
Scott McKinley, Chief Executive Officer
Board Chair, University of Silicon Valley. Former Managing Director, JPMorgan. Global Lead, AWS Academy (1 million+ students). Co-Founder and CEO, Neumont University.
Clinically validated voice-biomarker platform with 23 issued patents and peer-reviewed research. Built by Canary Speech, deployed in healthcare settings, and now purpose-built for financial services risk intelligence.
TruVX is an Open Technology Incubator (OTI) company, powered by Canary Speech's patented voice biomarker platform — the same technology deployed by Teladoc and GlobalMed in healthcare settings, now purpose-built for financial services. OTI was co-founded by Travis Oliphant, creator of NumPy and SciPy and co-founder of Anaconda.
TruVX is built for financial institutions, insurers, wealth management firms and enterprise contact centers. If your organization depends on high-stakes conversations, we should talk.
A 30-minute discovery call with our team to understand your use case and whether TruVX is the right fit.